Evidence map›Paper›PMID 38780516›Full record

ArticleTechnology in cancer research & treatment

Based on Gadolinium Ethoxybenzyl DTPA-Enhanced MRI: Diagnostic Performance of the Category-Modified LR-5 Criteria in Patients At Risk for Hepatocellular Carcinoma.

Shaopeng Li, Kexue Deng, Jun Qiu, Peng Wang, Dawei Yin, Yiju Xie, Yongqiang Yu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Technology in cancer research & treatment. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Shaopeng LiDepartmentof Radiology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.ORCID 0000-0002-8558-9816
Kexue DengDepartmentof Radiology, The First Affiliated Hospital of University of Science and Technology of China(Southern District of Anhui Provincial Hospital), Hefei, Anhui, China.
Jun QiuDepartmentof Radiology, The First Affiliated Hospital of University of Science and Technology of China(Southern District of Anhui Provincial Hospital), Hefei, Anhui, China.
Peng WangDepartmentof Radiology, The First Affiliated Hospital of University of Science and Technology of China(Southern District of Anhui Provincial Hospital), Hefei, Anhui, China.
Dawei YinDepartmentof Radiology, The First Affiliated Hospital of University of Science and Technology of China(Southern District of Anhui Provincial Hospital), Hefei, Anhui, China.
Yiju XieDepartmentof Radiology, The First Affiliated Hospital of University of Science and Technology of China(Southern District of Anhui Provincial Hospital), Hefei, Anhui, China.
Yongqiang YuDepartmentof Radiology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.ORCID 0000-0001-7222-9822

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Carcinoma, HepatocellularContrast MediaGadolinium DTPALiver NeoplasmsMagnetic Resonance ImagingAdultAgedFemaleHumansImage EnhancementMaleMiddle AgedRetrospective StudiesContrast MediaGadolinium DTPAgadolinium ethoxybenzyl DTPAgadolinium ethoxybenzyl DTPAhepatocellular carcinomaliver imaging reporting and data systemmagnetic resonance imagingmajor feature

Identifiers

PMID38780516
PMCPMC11131403

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.